Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
DuPont de Nemours
DD
|
$3.03B |
| 2 |
British American Tobacco
BTI
|
$722M |
| 3 |
CELG
Celgene Corp
CELG
|
$691M |
| 4 |
Becton Dickinson
BDX
|
$681M |
| 5 |
Baker Hughes
BKR
|
$671M |
Top Sells
| 1 |
DD
Du Pont De Nemours E I
DD
|
$2.75B |
| 2 |
Apple
AAPL
|
$1.8B |
| 3 |
BHI
Baker Hughes
BHI
|
$1.26B |
| 4 |
Medtronic
MDT
|
$1.17B |
| 5 |
Charter Communications
CHTR
|
$1.08B |
Sector Composition
| 1 | Financials | 16.6% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 14.29% |
| 4 | Communication Services | 11.08% |
| 5 | Consumer Discretionary | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
51
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.66B | 0.32% |
18,958,933
-2,415,344
| -11% | -$339M |
|
52
Intuitive Surgical
ISRG
$170B
| $2.6B | 0.31% |
2,486,514
-238,450
| -9% | -$249M |
|
|
CELG
53
DELISTED
Celgene Corp
CELG
| $2.53B | 0.31% |
17,334,657
+4,740,190
| +38% | +$691M |
|
54
Vertex Pharmaceuticals
VRTX
$100B
| $2.52B | 0.3% |
16,560,445
-1,923,268
| -10% | -$292M |
|
55
Procter & Gamble
PG
$368B
| $2.49B | 0.3% |
27,414,225
-4,421,773
| -14% | -$402M |
|
|
56
British American Tobacco
BTI
$124B
| $2.45B | 0.3% |
39,287,497
+11,560,132
| +42% | +$722M |
|
57
RTX Corp
RTX
$212B
| $2.44B | 0.3% |
21,048,466
+457,887
| +2% | +$53.2M |
|
58
Caterpillar
CAT
$196B
| $2.4B | 0.29% |
19,218,596
-395,065
| -2% | -$49.3M |
|
59
Philip Morris
PM
$260B
| $2.34B | 0.28% |
21,120,946
+201,745
| +1% | +$22.4M |
|
60
GE Aerospace
GE
$292B
| $2.33B | 0.28% |
96,549,383
-30,182,499
| -24% | -$730M |
|
61
Northrop Grumman
NOC
$84.5B
| $2.31B | 0.28% |
8,011,984
+716,246
| +10% | +$206M |
|
62
Monster Beverage
MNST
$60.9B
| $2.3B | 0.28% |
41,590,983
-401,240
| -1% | -$22.2M |
|
63
Walt Disney
DIS
$213B
| $2.25B | 0.27% |
22,866,097
-8,922,880
| -28% | -$880M |
|
64
Gilead Sciences
GILD
$140B
| $2.25B | 0.27% |
27,711,666
+4,674,363
| +20% | +$379M |
|
65
Biogen
BIIB
$19.4B
| $2.24B | 0.27% |
7,151,969
+1,047,943
| +17% | +$328M |
|
66
American Tower
AMT
$95.5B
| $2.23B | 0.27% |
16,281,013
-585,542
| -3% | -$80M |
|
|
67
Charter Communications
CHTR
$36.3B
| $2.13B | 0.26% |
5,851,463
-2,984,924
| -34% | -$1.08B |
|
68
PNC Financial Services
PNC
$81.7B
| $2.1B | 0.25% |
15,588,627
-87,987
| -0.6% | -$11.9M |
|
69
Capital One
COF
$145B
| $2.07B | 0.25% |
24,424,104
+2,151,722
| +10% | +$182M |
|
70
Exelon
EXC
$44.1B
| $2.04B | 0.25% |
54,112,282
+265,369
| +0.5% | +$10M |
|
71
Williams Companies
WMB
$70.7B
| $2.02B | 0.24% |
67,454,023
-7,914,915
| -11% | -$238M |
|
72
Estee Lauder
EL
$33B
| $2.02B | 0.24% |
18,770,293
-226,760
| -1% | -$24.5M |
|
73
Bristol-Myers Squibb
BMY
$96B
| $1.97B | 0.24% |
30,909,005
-5,684,461
| -16% | -$362M |
|
74
TJX Companies
TJX
$152B
| $1.94B | 0.23% |
26,290,054
-1,213,853
| -4% | -$89.5M |
|
75
Cognizant
CTSH
$35.3B
| $1.93B | 0.23% |
26,611,191
+1,545,439
| +6% | +$112M |
|